PARSABIV
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Jul 2024)
What this means for you
Registered since 20 Mar 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86523783
- Registration number
- 5428730
- Mark type
- Stylized text
- Filed
- 04 Feb 2015
- Published for opposition
- 29 Dec 2015
- Registered
- 20 Mar 2018
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Jul 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 20 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Mar 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Mar 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2018 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Feb 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED